JAPAN – Pear Therapeutics Inc., and SoftBank Group Corp have agreed to collaborate on the development of a Japanese-language digital therapeutic for sleep/wake disorders for the Japanese market. This strategic…
Read MoreSaturday, April 1, 2023
No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa